These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10084387)

  • 1. Dynamic effects of intravenous procainamide infusion on the electrophysiological properties during atrial fibrillation.
    Shima T; Ohnishi Y; Inoue T; Yokoyama M
    Jpn Circ J; 1999 Jan; 63(1):43-9. PubMed ID: 10084387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
    Vereckei A; Warman E; Mehra R; Zipes DP
    J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of procainamide on the postrepolarization refractoriness in cardiac muscle: evaluation using the block coupling interval in the artificial isthmus model in the canine right atrium.
    Yoshizawa N; Niwano S; Moriguchi M; Kitano Y; Inuo K; Saito J; Izumi T
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1100-7. PubMed ID: 11475826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophasic action potentials of the right atrium in patients with paroxysmal atrial fibrillation.
    Sekiya J; Ohnishi Y; Inoue T; Yokoyama M
    Jpn Circ J; 2001 Oct; 65(10):893-6. PubMed ID: 11665794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of procainamide on electrical activity in thoracic veins and atria in canine model of sustained atrial fibrillation.
    Chou CC; Zhou S; Miyauchi Y; Pak HN; Okuyama Y; Fishbein MC; Karagueuzian HS; Chen PS
    Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1936-45. PubMed ID: 15072975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid drug infusion for termination of atrial fibrillation in an experimental model.
    Arzbaecher R; Gemperline J; Haklin M; Buscemi P
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):288-91. PubMed ID: 9474690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis.
    Pagé PL; Hassanalizadeh H; Cardinal R
    Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of right atrial and peripheral procainamide infusion levels in patients with spontaneous or induced atrial fibrillation.
    Lurie KG; Buscemi PJ; Iskos D; Adkisson W; Fahy GJ; Sakaguchi S; Hoff J; Benditt DG
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):277-83. PubMed ID: 9474688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of termination and perpetuation of atrial fibrillation.
    Asano Y; Saito J; Matsumoto K; Kaneko K; Yamamoto T; Uchida M
    Am J Cardiol; 1992 Apr; 69(12):1033-8. PubMed ID: 1561974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
    Daoud EG; Knight BP; Weiss R; Bahu M; Paladino W; Goyal R; Man KC; Strickberger SA; Morady F
    Circulation; 1997 Sep; 96(5):1542-50. PubMed ID: 9315545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant prolongation of atrial monophasic action potential duration: short-term reverse electrophysiological changes after internal cardioversion of atrial fibrillation.
    Korte T; Niehaus M; Borchert G; Tebbenjohanns J
    Cardiovasc Res; 2002 Mar; 53(4):944-51. PubMed ID: 11922904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
    Lai LP; Lin JL; Lien WP; Tseng YZ; Huang SK
    J Am Coll Cardiol; 2000 May; 35(6):1434-41. PubMed ID: 10807444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiological properties of atrial fibrillation with WPW syndrome and the role of procainamide in conversion].
    Li P
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Apr; 19(2):65-6, 123. PubMed ID: 1879311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation.
    Minami T; Isomoto S; Nakao K; Komiya N; Fukae S; Centurion OA; Yano K
    Pacing Clin Electrophysiol; 2004 Feb; 27(2):212-7. PubMed ID: 14764172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF; Fabritz CL; Franz MR
    Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
    Yu WC; Chen SA; Lee SH; Tai CT; Feng AN; Kuo BI; Ding YA; Chang MS
    Circulation; 1998 Jun; 97(23):2331-7. PubMed ID: 9639377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart.
    Hayashi H; Fujiki A; Tani M; Usui M; Inoue H
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):101-7. PubMed ID: 9456284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.